- Home
- CELZ vs ALBT Comparison
CELZ vs ALBT Comparison
Compare CELZ & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- ALBT
- Stock Information
- Founded
- CELZ 1998
- ALBT 2014
- Country
- CELZ United States
- ALBT United States
- Employees
- CELZ N/A
- ALBT N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CELZ Health Care
- ALBT Health Care
- Exchange
- CELZ Nasdaq
- ALBT Nasdaq
- Market Cap
- CELZ 10.4M
- ALBT 8.4M
- IPO Year
- CELZ N/A
- ALBT N/A
- Fundamental
- Price
- CELZ $5.59
- ALBT $2.10
- Analyst Decision
- CELZ
- ALBT
- Analyst Count
- CELZ 0
- ALBT 0
- Target Price
- CELZ N/A
- ALBT N/A
- AVG Volume (30 Days)
- CELZ 88.8K
- ALBT 43.7K
- Earning Date
- CELZ 11-12-2025
- ALBT 11-13-2025
- Dividend Yield
- CELZ N/A
- ALBT N/A
- EPS Growth
- CELZ N/A
- ALBT N/A
- EPS
- CELZ N/A
- ALBT N/A
- Revenue
- CELZ $6,000.00
- ALBT $1,159,091.00
- Revenue This Year
- CELZ N/A
- ALBT N/A
- Revenue Next Year
- CELZ N/A
- ALBT N/A
- P/E Ratio
- CELZ N/A
- ALBT N/A
- Revenue Growth
- CELZ N/A
- ALBT N/A
- 52 Week Low
- CELZ $1.69
- ALBT $1.87
- 52 Week High
- CELZ $6.90
- ALBT $11.66
- Technical
- Relative Strength Index (RSI)
- CELZ 82.55
- ALBT 33.62
- Support Level
- CELZ $3.35
- ALBT $2.13
- Resistance Level
- CELZ $4.23
- ALBT $2.24
- Average True Range (ATR)
- CELZ 0.40
- ALBT 0.11
- MACD
- CELZ 0.20
- ALBT -0.01
- Stochastic Oscillator
- CELZ 77.63
- ALBT 7.67
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.